ONCAlert | 2017 NANETS Symposium

Nab-Paclitaxel as Neoadjuvant Therapy for Breast Cancer

Yu (Amy) Zong
Published Online:12:13 PM, Wed February 1, 2017

Yu (Amy) Zong, Shanghai Jiaotong University School of Medicine, discusses a meta-analysis of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) as neoadjuvant chemotherapy of breast cancer. 
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.